Expanded Access Protocol for STOMP-II Patients Who Were Unable to Receive Treatment Subsequent to Adipose Tissue Collection (EAP-STOMP2)
Expanded Access Protocol for STOMP-II Patients Who Were Unable to Receive Treatment Subsequent to Adipose Tissue Collection (EAP-STOMP2)
Sponsor: Alimentiv Inc.
Listed as NCT06509828, this observational or N/A phase trial focuses on Perianal Fistula Due to Crohn's Disease and remains ongoing. Sponsored by Alimentiv Inc., it has been updated 2 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Sep 2024 — Present [monthly]
Available
-
Aug 2024 — Sep 2024 [monthly]
Available
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Alimentiv Inc.
- Avobis Bio, LLC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.